CorMedix Inc. (CRMD) |
|
3.45 -0.17 (-4.7%)
|
06-26 22:15 |
|
Open: |
3.63 |
Pre. Close: |
3.62 |
|
High:
|
3.79 |
Low:
|
3.3 |
|
Volume:
|
4,726,131 |
Market Cap:
|
135(M) |
|
|
|
|
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.79 - 3.81 |
3.81 - 3.83 |
|
Low:
|
3.26 - 3.28 |
3.28 - 3.29 |
|
Close:
|
3.42 - 3.45 |
3.45 - 3.48 |
|
Technical analysis |
as of: 2022-06-24 4:39:01 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 4.42  One year: 5.17 |
| Support: |
Support1: 3.08 Support2: 2.64 |
| Resistance: |
Resistance1: 3.78 Resistance2: 4.42 |
| Pivot: |
3.02 |
| Moving Average: |
MA(5): 3.21 MA(20): 3.03
MA(100): 4.07  MA(250): 4.77 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 85.1 %D(3): 70.5 |
| RSI: |
RSI(14): 56.9 |
| 52-week: |
High: 7.15 Low: 2.64 |
| Average Vol(K): |
3-Month: 413 (K) 10-Days: 683 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CRMD ] has closed below upper band by 7.0%. Bollinger Bands are 16% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sun, 26 Jun 2022
CorMedix (NYSE:CRMD) Shares Down 4.7% - Defense World
Sat, 04 Jun 2022
Brokerages Anticipate CorMedix Inc. (NYSE:CRMD) to Announce -$0.20 Earnings Per Share - Defense World
Tue, 17 May 2022
CorMedix Inc. (NYSEAMERICAN:CRMD) CEO Joseph Todisco Acquires 10000 Shares - Defense World
Fri, 13 May 2022
CorMedix Inc Common Stock (CRMD) Q1 2022 Earnings Call Transcript - The Motley Fool
Mon, 28 Mar 2022
CRMD stock rises on FDA acceptance of marketing application for lead asset (NASDAQ:CRMD) - Seeking Alpha
Thu, 17 Mar 2022
Health Care Sector Update for 03/17/2022: CPRX,CRMD,AMRX,INM - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
0 (M) |
| Shares Float |
38 (M) |
|
% Held by Insiders
|
3.825e+007 (%) |
|
% Held by Institutions
|
1.7 (%) |
|
Shares Short
|
2,420 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.938e+007 |
|
EPS Est Next Qtl
|
-0.13 |
|
EPS Est This Year
|
-0.53 |
|
EPS Est Next Year
|
-0.29 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-15 |
|
Return on Assets (ttm)
|
417.5 |
|
Return on Equity (ttm)
|
-31.2 |
|
Qtrly Rev. Growth
|
190940 |
|
Gross Profit (p.s.)
|
0.52 |
|
Sales Per Share
|
-23.23 |
|
EBITDA (p.s.)
|
18502.2 |
|
Qtrly Earnings Growth
|
-0.8 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-21 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
-0.15 |
|
Price to Cash Flow
|
4.3 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
2.87e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-03-25 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
